Kaplan–Meier probability analyses confirmed the associations of chi‐square analyses and illustrated that GnRH agonists alone exerted the greatest acceleration of AD incidence, followed by androgen receptor inhibitors, and ketoconazole. Here, GNRH1 is linked to Alzheimer disease.